SD

Sudhir Dolatrai Desai

Director Director DIN 03429769
DIN 03429769 First appointment Mar 2011 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Past companies 2 historical roles
Total affiliations 2 Since Mar 2011
Shareholding value •••• Premium profile

About Sudhir Dolatrai Desai

Data last updated:

Sudhir Dolatrai Desai was a Director at Kavbir Pharmaceutical Private Limited (2015–2018) and Director at Glopharm Laboratories Private Limited (2011–2017). The companies operate in Pharma and Healthcare.

DIN 03429769
Primary Designation Director
Industry Pharma
First Appointment 31 Mar 2011

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director28 Sep 20152015₹44.2 Lakh (FY 2017)Strike Off
Director31 Mar 20112011₹1.32 Cr (FY 2024)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Kavbir Pharmaceutical Private Limited
Glopharm Laboratories Private Limited
Premium access

Shareholding and investment profile for Sudhir Dolatrai Desai

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sudhir Dolatrai Desai

Sudhir Dolatrai Desai was first appointed on 31 Mar 2011 as Director at Glopharm Laboratories Private Limited. The most recent appointment on record is 28 Sep 2015 at Kavbir Pharmaceutical Private Limited.

Sudhir Dolatrai Desai held 2 earlier board appointments: Kavbir Pharmaceutical Private Limited (Director, 28 Sep 2015 to 10 Oct 2018); Glopharm Laboratories Private Limited (Director, 31 Mar 2011 to 18 Jul 2017).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available